Skip to main content
. 2015 Feb 1;2015:729831. doi: 10.1155/2015/729831

Figure 2.

Figure 2

TM-1 administered 3 or 4 h after injury reduced the TBI-induced AQP1 mRNA expression measured 8 and 24 h after TBI. Relative AQP1 mRNA expression was measured by reverse transcription Q-PCR using β-actin (a) and Gapdh (b) as reference genes. AQP1 mRNA expression significantly decreased following TM-1 administration (10 mg/kg) at 3 and 4 h after injury in the rats sacrificed 8 or 24 h after injury, respectively. Compared with the TBI + veh groups, the TM-1 treated groups exhibited significantly decreased mRNA expression. Data are expressed as mean ± SD (n = 5/group). *** P < 0.001 TBI + veh group compared with the sham-operated group; # P < 0.05 and ### P < 0.0001 TM-1 treated group compared with the TBI + veh groups; +++ P < 0.001, comparison between mRNA expression following TM-1 administration (10 mg/kg) 3 and 4 h after injury in the rats sacrificed 8 or 24 h after TBI.